| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 1/2 | |||
| NCT06121297 | RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201… | Systemic Lupus Erythematosus | Recruiting |
| NCT06328777 | RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a… | Systemic Sclerosis | Recruiting |
| NCT04422912 | A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3… | Pemphigus Vulgaris | Recruiting |
| NCT06359041 | RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With… | Generalized Myasthenia Gravis (gMG) | Active, Not Recruiting |